Xiaoyu An

448 total citations
32 papers, 255 citations indexed

About

Xiaoyu An is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Xiaoyu An has authored 32 papers receiving a total of 255 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Immunology, 11 papers in Oncology and 7 papers in Molecular Biology. Recurrent topics in Xiaoyu An's work include Immunotherapy and Immune Responses (9 papers), CAR-T cell therapy research (6 papers) and Phagocytosis and Immune Regulation (6 papers). Xiaoyu An is often cited by papers focused on Immunotherapy and Immune Responses (9 papers), CAR-T cell therapy research (6 papers) and Phagocytosis and Immune Regulation (6 papers). Xiaoyu An collaborates with scholars based in China, United States and Singapore. Xiaoyu An's co-authors include Qi‐Xiang Li, Xuesong Ouyang, Gerold Feuer, Gang Liu, Rajendra Kumari, Gethin Thomas, Mark Harris, Katharine M. Irvine, Ranjeny Thomas and Demin Zhou and has published in prestigious journals such as Angewandte Chemie International Edition, Nano Letters and Blood.

In The Last Decade

Xiaoyu An

29 papers receiving 229 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Xiaoyu An China	9	100	99	84	44	41	32	255
Hadi Nasiri Iran	9	101 1.0×	54 0.5×	132 1.6×	37 0.8×	21 0.5×	19	283
Rosmely Hernandez United States	9	166 1.7×	229 2.3×	99 1.2×	25 0.6×	39 1.0×	12	375
Stephanie Stahnke Germany	6	164 1.6×	299 3.0×	100 1.2×	46 1.0×	28 0.7×	8	423
Shouhui Du Singapore	9	141 1.4×	91 0.9×	162 1.9×	29 0.7×	67 1.6×	10	287
Heng Yang China	10	186 1.9×	104 1.1×	178 2.1×	19 0.4×	30 0.7×	16	389
Anne de Dreu Netherlands	4	47 0.5×	112 1.1×	88 1.0×	53 1.2×	25 0.6×	5	236
Brooke Lumicisi United Kingdom	5	57 0.6×	124 1.3×	184 2.2×	16 0.4×	25 0.6×	5	346
Anne Showalter United States	4	119 1.2×	122 1.2×	141 1.7×	96 2.2×	15 0.4×	6	350
Genee Lee United States	6	123 1.2×	50 0.5×	170 2.0×	42 1.0×	20 0.5×	6	295
Caitlin M. Tilsed Australia	8	140 1.4×	115 1.2×	72 0.9×	37 0.8×	16 0.4×	15	265

Countries citing papers authored by Xiaoyu An

Since Specialization

Citations

This map shows the geographic impact of Xiaoyu An's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoyu An with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoyu An more than expected).

Fields of papers citing papers by Xiaoyu An

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoyu An. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoyu An. The network helps show where Xiaoyu An may publish in the future.

Co-authorship network of co-authors of Xiaoyu An

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoyu An. A scholar is included among the top collaborators of Xiaoyu An based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoyu An. Xiaoyu An is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

An, Xiaoyu, et al.. (2025). dsRNAEngineer: a web-based tool of comprehensive dsRNA design for pest control. Trends in biotechnology. 43(4). 969–983. 11 indexed citations

2.

Xue, Cong, Wei Yang, Anqi Hu, et al.. (2025). CYP2D6 polymorphisms and endoxifen concentration in Chinese patients with breast cancer. BMC Cancer. 25(1). 410–410. 1 indexed citations

3.

Zhang, Lei, et al.. (2025). FOSL1 promotes keratinocyte migration and wound repair by modulating the IL17 signaling pathway. Scientific Reports. 15(1). 16457–16457. 2 indexed citations

4.

An, Xiaoyu, Wei Xiang, Xue Liu, et al.. (2024). A Bioengineered Nanovesicle Vaccine Boosts T‐B cell Interaction for Immunotherapy of Echinococcus multilocularis. Angewandte Chemie. 136(13). 1 indexed citations

5.

An, Xiaoyu, Wei Xiang, Xue Liu, et al.. (2024). A Bioengineered Nanovesicle Vaccine Boosts T‐B cell Interaction for Immunotherapy of Echinococcus multilocularis. Angewandte Chemie International Edition. 63(13). e202319489–e202319489. 10 indexed citations

6.

An, Xiaoyu, et al.. (2024). Enzymes in Synergy: Bacteria Specific Molecular Probe for Locoregional Imaging of Urinary Tract Infection in vivo. Angewandte Chemie. 136(33). 4 indexed citations

7.

Yang, Tao, Jinping Liu, Xiaoyu An, et al.. (2024). Narazaciclib, a novel multi-kinase inhibitor with potent activity against CSF1R, FLT3 and CDK6, shows strong anti-AML activity in defined preclinical models. Scientific Reports. 14(1). 9032–9032. 2 indexed citations

8.

Yang, Tao, Faming Zhang, Cen Chen, et al.. (2024). Preclinical pharmacology characterization of HX009, a novel PD1 x CD47 Bi-specific antibody. Scientific Reports. 14(1). 28201–28201.

9.

An, Xiaoyu, et al.. (2023). Abstract 2980: HX009, a first-in-class PD1xCD47 BsAb, demonstrated anti-AML activity in PDX models. Cancer Research. 83(7_Supplement). 2980–2980. 1 indexed citations

10.

Zhang, Faming, Jingjing Wang, Xiaoyu An, et al.. (2023). HX009, a novel BsAb dual targeting PD1 x CD47, demonstrates potent anti-lymphoma activity in preclinical models. Scientific Reports. 13(1). 5419–5419. 15 indexed citations

11.

An, Xiaoyu, et al.. (2023). Designing nanodiscs as versatile platforms for on-demand therapy. Nanoscale. 16(5). 2220–2234. 4 indexed citations

12.

An, Xiaoyu, Yun Zeng, Chao Liu, & Gang Liu. (2023). Cellular-Membrane-Derived Vesicles for Cancer Immunotherapy. Pharmaceutics. 16(1). 22–22. 10 indexed citations

13.

Jin, Ying, Xiaoyu An, Binchen Mao, et al.. (2022). Different syngeneic tumors show distinctive intrinsic tumor-immunity and mechanisms of actions (MOA) of anti-PD-1 treatment. Scientific Reports. 12(1). 3278–3278. 40 indexed citations

14.

An, Xiaoyu, Henry Li, Faming Zhang, et al.. (2022). 491 Preclinical pharmacology modeling of HX009, a clinical stage first-in-class PD-1xCD47 BsAb, for anti-lymphoma applications. Regular and Young Investigator Award Abstracts. A512–A512. 1 indexed citations

15.

Kumari, Rajendra, Xuesong Ouyang, Jingjing Wang, et al.. (2021). Preclinical pharmacology modeling of chimeric antigen receptor T therapies. Current Opinion in Pharmacology. 61. 49–61. 17 indexed citations

16.

An, Xiaoyu & Fuxin Zhao. (2021). Prediction of soil moisture based on BP neural network optimized search algorithm. IOP Conference Series Earth and Environmental Science. 714(2). 22046–22046. 2 indexed citations

17.

An, Xiaoyu, Xuesong Ouyang, Hui Zhang, et al.. (2018). Immunophenotyping of Orthotopic Homograft (Syngeneic) of Murine Primary KPC Pancreatic Ductal Adenocarcinoma by Flow Cytometry. Journal of Visualized Experiments. 5 indexed citations

18.

An, Xiaoyu, et al.. (2018). Abstract 4059: Vaccination causes a clear subtype shifting of tumor infiltrate Treg in mouse breast cancer homografts. Cancer Research. 78(13_Supplement). 4059–4059. 3 indexed citations

19.

An, Xiaoyu, Jinping Liu, Na Wang, et al.. (2016). AC220 and AraC cause differential inhibitory dynamics in patient-derived M5-AML with FLT3-ITD and, thus, ultimately distinct therapeutic outcomes. Experimental Hematology. 45. 36–44.e2. 7 indexed citations

20.

Irvine, Katharine M., Patricia Gallego, Xiaoyu An, et al.. (2012). Peripheral Blood Monocyte Gene Expression Profile Clinically Stratifies Patients With Recent-Onset Type 1 Diabetes. Diabetes. 61(5). 1281–1290. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact